Does UPADACITINIB Cause Psoriasis? 504 Reports in FDA Database

Q: Does UPADACITINIB cause Psoriasis?

504 reports of Psoriasis have been filed with the FDA for UPADACITINIB, representing 0.8% of all UPADACITINIB adverse event reports.

Q: How dangerous is Psoriasis from UPADACITINIB?

Of 504 reports, 82 (16.3%) resulted in death and 145 required hospitalization.

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 504 reports of Psoriasis have been filed in association with UPADACITINIB (Rinvoq). This represents 0.8% of all adverse event reports for UPADACITINIB.

504

Reports of Psoriasis with UPADACITINIB

0.8%

of all UPADACITINIB reports

Deaths

145

Hospitalizations

How Dangerous Is Psoriasis From UPADACITINIB?

Of the 504 reports, 82 (16.3%) resulted in death, 145 (28.8%) required hospitalization, and 81 (16.1%) were considered life-threatening.

Is Psoriasis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 504 reports have been filed with the FAERS database.

What Other Side Effects Does UPADACITINIB Cause?

Pain (4,444) Arthralgia (3,815) Drug ineffective (3,384) Covid-19 (2,978) Rheumatoid arthritis (2,730) Pain in extremity (2,353) Fatigue (2,153) Fall (2,081) Surgery (2,037) Therapy interrupted (1,741)

What Other Drugs Cause Psoriasis?

SECUKINUMAB (21,976) APREMILAST (19,255) ADALIMUMAB (16,698) ETANERCEPT (10,818) RISANKIZUMAB-RZAA (6,896) METHOTREXATE (6,283) USTEKINUMAB (4,955) INFLIXIMAB (3,524) CERTOLIZUMAB PEGOL (3,428) IXEKIZUMAB (2,818)

Which UPADACITINIB Alternatives Have Lower Psoriasis Risk?

UPADACITINIB vs URAPIDIL UPADACITINIB vs UREA UPADACITINIB vs URIDINE TRIACETATE UPADACITINIB vs UROFOLLITROPIN UPADACITINIB vs URSODIOL

UPADACITINIB Full Profile All Psoriasis Reports All Drugs Causing Psoriasis UPADACITINIB Demographics